Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 5.0B | 5.0B | 6.7B | 6.5B |
| Cost of revenue | 3.5B | 3.5B | 4.6B | 4.5B |
| Gross profit | 1.5B | 1.5B | 2.1B | 2.0B |
| Operating expense | ||||
| Research & development | 219.9M | 255.1M | 239.8M | 239.4M |
| Selling general and admin | 202.2M | 208.9M | 249.2M | 270.8M |
| Other operating expenses | — | — | — | — |
| Operating income | 1.1B | 1.0B | 1.6B | 1.5B |
| Non operating interest income | ||||
| Income | 55.7M | 75.8M | 49.4M | 52.6M |
| Expense | 14.1M | 14.3M | 19.3M | 15.6M |
| Other income expense | — | — | — | — |
| Pretax income | 1.1B | 1.2B | 1.5B | 1.5B |
| Tax provision | 201.0M | 244.6M | 280.1M | 198.2M |
| Net income | 850.7M | 976.7M | 1.2B | 1.3B |
| Basic EPS | 9.7 | — | 14.1 | 14.7 |
| Diluted EPS | 9.7 | — | 14.0 | 14.6 |
| Basic average shares | 87.4M | — | 87.3M | 87.4M |
| Diluted average shares | 87.8M | — | 87.8M | 87.7M |
| EBITDA | 1.1B | 1.3B | 1.6B | 1.6B |
| Net income from continuing op. | 1.1B | 1.2B | 1.5B | 1.5B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | 0 | 0 | 0 | 0 |